Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2008
12/10/2008CN100441161C Multi-cored molded article, method of producing the same, and device for producing the same
12/10/2008CN100441103C Coated chewing gum
12/09/2008US7462703 For use in gene therapy
12/09/2008US7462645 Bronchodilating beta-agonist compositions and methods
12/09/2008US7462626 Compositions for affecting weight loss
12/09/2008US7462606 Antiseptics; surgery; controlling release of drugs
12/09/2008US7462603 Artificial micelle comprising shuttle vector for use as tool in efficient gene transfer to cells
12/09/2008US7462596 Pharmaceutical compositions comprising MBL and/or MBL variants. In particular the invention relates to pharmaceutical compositions comprising at least 200 mu g/ml protein containing material, wherein mannan binding lectin and
12/09/2008US7462592 Compositions and methods for polynucleotide delivery
12/09/2008US7462367 Anticholinergic powder formulations for inhalation
12/09/2008US7462366 Drug delivery particle
12/09/2008US7462365 specific combination of excipients exhibits an increase of bioavailability of the polypeptide; namely a sugar and salting-out salt are present in sustained release composition
12/09/2008US7462362 10 weight % terbinafine hydrochloride, 0.5 % dodecyl 2-(N,N-dimethylamino)propionate hydrochloride and 0.75 % benzyl alcohol to enhance penetration; 0.5 % polyvinylpyrrolidone, and the remainder ethanol; duel delivery through nail and skin increases topical bioavailability; onychomycosis
12/09/2008US7462361 N,N-dihalogenated amino acids and derivatives
12/09/2008US7462348 Self-inflating article
12/09/2008US7462232 Microcrystalline cellulose compositions
12/09/2008CA2515094C Transdermal granisetron
12/09/2008CA2389650C Composition for treatment of constipation and irritable bowel syndrome
12/09/2008CA2387953C Compositions for electroporation
12/09/2008CA2387193C Compositions for electroporation
12/09/2008CA2326485C Anticancer compositions
12/09/2008CA2306486C Method and compositions for in situ formation of protective and/or medicated films on body tissue
12/09/2008CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
12/09/2008CA2215203C Vaccines for plague
12/09/2008CA2214737C Microparticles, media containing the latter for ultrasonic diagnosis as well as process for the production of the particles and media
12/09/2008CA2201526C Differentially biodegradable biomedical implants
12/04/2008WO2008148080A2 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
12/04/2008WO2008148019A1 Methods of making and using nano scale particles
12/04/2008WO2008148018A2 Rapidly dispersible vaginal tablet that provides a bioadhesive gel
12/04/2008WO2008148015A1 Sustained release formulation of melatonin
12/04/2008WO2008147968A1 System for seamless and secure networking of implantable medical devices, electronic patch devices and wearable devices
12/04/2008WO2008147936A1 Implantable device and method for transvascular neuromodulation
12/04/2008WO2008147843A1 Methods for improving physical function in fibromyalgia
12/04/2008WO2008147817A2 Coated hyaluronic acid particles
12/04/2008WO2008147772A1 Film shreds and delivery systems incorporating same
12/04/2008WO2008147715A2 Multi-dose concentrate esmolol with benzyl alcohol
12/04/2008WO2008147438A2 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
12/04/2008WO2008147417A1 Method of treating diabetes
12/04/2008WO2008147245A2 Controlled release proxodolol pharmaceutical composition
12/04/2008WO2008146796A1 Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
12/04/2008WO2008146795A1 Percutaneously absorbable preparation
12/04/2008WO2008146732A1 Infusion solution for peripheral intravenous administration
12/04/2008WO2008146731A1 Method for preparation of infusion solution for peripheral intravenous administration
12/04/2008WO2008146721A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/04/2008WO2008146710A1 Skin whitening agent
12/04/2008WO2008146590A1 Spherical mannitol crystal particle
12/04/2008WO2008146178A2 A novel tablet dosage form
12/04/2008WO2008146104A2 Stable liquid composition of chondroitinsulfate and glucosamine
12/04/2008WO2008146018A2 Drug delivery system comprising matrix metalloproteinase inhibitors
12/04/2008WO2008146016A2 Cyclodextrins for administering fatty acids in tablets
12/04/2008WO2008145943A2 Vehicle in the form of a water-in-oil emulsion in particular for ophthalmic or dermocosmetic use
12/04/2008WO2008145750A2 Method for coating surfaces with micro- and nanoparticles with the aid of plasma methods
12/04/2008WO2008145744A1 Oil-in-water emulsion and its use for the delayed release of active elements
12/04/2008WO2008145732A1 Stable non-aqueous pharmaceutical compositions
12/04/2008WO2008145730A1 Stable non-aqueous pharmaceutical compositions
12/04/2008WO2008145728A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
12/04/2008WO2008145361A1 Mineral-fiber solid dispersion, method for preparing the same, and use thereof as pharmaceutical tableting aid
12/04/2008WO2008145334A1 Method for the production of a form of administration of a medicament
12/04/2008WO2008145323A1 Pharmaceutical formulation for interferons
12/04/2008WO2008145298A1 Reconstituted surfactants having improved properties
12/04/2008WO2008145183A1 Oil-in-water emulsion and its use for the delayed release of active elements
12/04/2008WO2008145149A1 Antiphlogistic and analgesic composition for topical use in a region of an animal locomotive system
12/04/2008WO2008145143A1 Once daily oral dosage form comprising tacrolimus
12/04/2008WO2008145119A1 Transdermal tobacco alkaloid reservoir patch
12/04/2008WO2008144996A1 Stable pharmaceutical cucurbitacin liquid composition
12/04/2008WO2008144942A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008WO2008144888A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008WO2008144880A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
12/04/2008WO2008124165A3 Self-assembling nanoparticle drug delivery system
12/04/2008WO2008122638A3 Process for preparing pramipexole dihydrochloride tablets
12/04/2008WO2008116737A3 Capsule containing plant preparations
12/04/2008WO2008112836A3 Pharmaceutical composition comprising human growth hormon
12/04/2008WO2008103245A3 Method of determining the weight of the coating to be applied to form a controlled release dosage form
12/04/2008WO2008097328A9 Asymmetric functionalized nanoparticles and methods of use
12/04/2008WO2008091465A3 Peg and targeting ligands on nanoparticle surface
12/04/2008WO2008088922A9 Prevention of hydrogel viscosity loss
12/04/2008WO2008079697A3 Method of treating mucin deficiency with an active pharmaceutical and related composition
12/04/2008WO2008079290A3 Stable buffered formulations containing polypeptides
12/04/2008WO2008079245A3 Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
12/04/2008WO2008076333A8 Polymer-drug conjugates with tether groups for controlled drug delivery
12/04/2008WO2008063229A3 Enzymatic debridement therapy for abnormal cell proliferation
12/04/2008WO2008060173A3 Procedure and devices for the controlled obtaining of dry saline aerosols with therapeutic effect
12/04/2008WO2008039989A3 Formulations of dnase and methods of use thereof
12/04/2008WO2008036979A3 Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
12/04/2008WO2008035361A3 Device for delivering active ingredients to humans, animals and plants
12/04/2008WO2008028193A3 Colon-targeted oral formulations of cytidine analogs
12/04/2008WO2008020942A3 R-spondin compositions and methods of use thereof
12/04/2008WO2008005692A3 INHALANT FORMULATION CONTAINING SULFOALKYL ETHER γ-CYCLODEXTRIN AND CORTICOSTEROID
12/04/2008WO2007136404A3 Lysophospholipids solubilized single-walled carbon nanotubes
12/04/2008WO2007134533A8 20(R)-GINSENOSIDE Rg3 MEDICINAL SOLUBLE INTERMEDIATE AND PROCESS THEREOF
12/04/2008WO2007130873A3 Liver-specific nanocapsules and methods of using
12/04/2008WO2007127231A3 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof
12/04/2008WO2007127207A3 Fixed combination dosage forms for the treatment of migraine
12/04/2008WO2007120838A3 Rapidly disintegrating solid oral dosage form of liquid dispersions
12/04/2008WO2007106622A3 Fungicidal formulation and method of use
12/04/2008WO2007092161A3 A direct cellular energy delivery system
12/04/2008WO2006096269A3 Targeted gene deletions for polysaccharide slime formers
12/04/2008US20080300554 Lubricant for medical devices
12/04/2008US20080300315 Stabilized Compositions Comprising a Therapeutically Active Agent, and an Oxidizing Preservative
12/04/2008US20080300284 sustained release niacin formulation with side effect reduction of liver toxicity and effects on glucose metabolism and uric acid levels
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 2991